Rhythm Pharmaceuticals, Inc. financial data

Symbol
RYTM on Nasdaq
Industry
Pharmaceutical Preparations
Location
222 Berkeley Street, 12 Th Floor, Boston, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Former names
RHYTHM METABOLIC, INC. (to 8/12/2015)
Latest financial report
Q1 2024 - May 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 563 % -28.3%
Quick Ratio 15.1 %
Debt-to-equity 105 % +133%
Return On Equity -179 % -139%
Return On Assets -87.3 % -68.6%
Operating Margin -238 % +68.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 61 M shares +7.24%
Common Stock, Shares, Outstanding 61 M shares +7.23%
Entity Public Float 887 M USD +371%
Common Stock, Value, Issued 60 K USD +7.14%
Weighted Average Number of Shares Outstanding, Basic 60.1 M shares +6.06%
Weighted Average Number of Shares Outstanding, Diluted 57.7 M shares +10.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 77.4 M USD +228%
Research and Development Expense 226 M USD +97.8%
Costs and Expenses 364 M USD +71%
Operating Income (Loss) -272 M USD -51.8%
Nonoperating Income (Expense) -1.29 M USD +15.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -141 M USD -170%
Income Tax Expense (Benefit) 300 K USD
Net Income (Loss) Attributable to Parent -274 M USD -51.7%
Earnings Per Share, Basic -4.63 USD/shares -38.6%
Earnings Per Share, Diluted -3.2 USD/shares +7.78%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 53.4 M USD -51.3%
Cash, Cash Equivalents, and Short-term Investments 201 M USD -31.7%
Accounts Receivable, after Allowance for Credit Loss, Current 14.7 M USD +81%
Inventory, Net 8.51 M USD +55%
Other Assets, Current 6.67 M USD -10%
Assets, Current 236 M USD -25.8%
Other Long-term Investments 13.8 M USD -17.6%
Property, Plant and Equipment, Net 1.15 M USD -42.6%
Operating Lease, Right-of-Use Asset 670 K USD -38.4%
Other Assets, Noncurrent 15 M USD -9.94%
Assets 259 M USD -25.2%
Accounts Payable, Current 7.55 M USD -43.4%
Accrued Liabilities, Current 44.5 M USD +45.8%
Liabilities, Current 54.2 M USD +17.7%
Operating Lease, Liability, Noncurrent 284 K USD -73.6%
Other Liabilities, Noncurrent 34.6 M USD
Liabilities 197 M USD +56.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -181 K USD -2917%
Retained Earnings (Accumulated Deficit) -1.04 B USD -35.9%
Stockholders' Equity Attributable to Parent 61.6 M USD -72%
Liabilities and Equity 259 M USD -25.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -40.7 M USD -11.8%
Net Cash Provided by (Used in) Financing Activities 4.24 M USD
Net Cash Provided by (Used in) Investing Activities 30.1 M USD +62.7%
Common Stock, Shares Authorized 120 M shares 0%
Common Stock, Shares, Issued 61 M shares +7.23%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -6.52 M USD +63.8%
Deferred Tax Assets, Valuation Allowance 267 M USD +23%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 267 M USD +22.9%
Operating Lease, Liability 1.08 M USD -39.5%
Payments to Acquire Property, Plant, and Equipment 47 K USD -83.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -274 M USD -52.3%
Lessee, Operating Lease, Liability, to be Paid 1.14 M USD -42.3%
Property, Plant and Equipment, Gross 5.4 M USD +0.9%
Operating Lease, Liability, Current 793 K USD +12.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 502 K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 640 K USD -24.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 65 K USD -67.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 502 K USD -41%
Deferred Tax Assets, Operating Loss Carryforwards 154 M USD +13.4%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) 564 K USD
Preferred Stock, Shares Authorized 10 M shares 0%
Additional Paid in Capital 1.1 B USD +11.8%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 1 K USD
Amortization of Intangible Assets 855 K USD +10.5%
Depreciation, Depletion and Amortization 903 K USD +0.78%
Deferred Tax Assets, Net of Valuation Allowance 338 K USD -6.37%
Share-based Payment Arrangement, Expense 32.6 M USD +64.2%
Interest Expense 15.6 M USD +55.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%